Canopy recalls some adult-use cannabis in Canada

(This story has been updated to include information from the previously unpublished Health Canada recall notice.)

A voluntary recall has been issued for some of Canopy Growth’s whole flower cannabis brand “LBS Sunset” sold throughout Canada between Feb. 7 and Feb. 27.

The recall, which all provinces and territories in Canada have been made aware of, involves incorrect labeling.

The label has incorrect cannabinoid values, where the percentage of THC and percentage of CBD were reversed on the label, the recall notice stated, adding that neither Health Canada nor Tweed has received any adverse reaction reports for the recalled cannabis.

According to the company, the incorrect labels list:

  • THC levels less than 0.07%, when it should be 0.40%.
  • CBD levels of 0.40% when it should be less than 0.07%.
  • Total CBD level of less than 0.07% when it should read 0.08%.

“All these numbers round down to zero,” a company spokesperson told Marijuana Business Daily. “We are very sorry for the inconvenience, and we want to assure consumers that the dried flower itself is the 23% THC level it was labeled as.”

This is the eighth product recall since Canada legalized cannabis in October 2018 – and Canopy’s first in that time. No recall notices were posted in the nine months prior.

The other seven recalls were a result of labeling errors, mold or recordkeeping issues with production documents.

Alberta Gaming, Liquor and Cannabis Commission (AGLC) – the regulator of adult-use cannabis in the province – is asking retailers to remove the recalled products from store shelves, mark it “Do Not Sell – Recalled Product” and set it aside until further instructions are issued by the agency.

According to the AGLC, the lot and SKU number are SUN8213TSB and CNB006003620, respectively.

Canopy’s shares trade on the New York Stock Exchange under the ticker symbol CGC and on the Toronto Stock Exchange as WEED.